Specificity, versatility, and control of TGF-β family signaling
R Derynck, EH Budi - Science signaling, 2019 - science.org
Encoded in mammalian cells by 33 genes, the transforming growth factor–β (TGF-β) family
of secreted, homodimeric and heterodimeric proteins controls the differentiation of most, if …
of secreted, homodimeric and heterodimeric proteins controls the differentiation of most, if …
TGF-β receptors: In and beyond TGF-β signaling
A Vander Ark, J Cao, X Li - Cellular signalling, 2018 - Elsevier
Transforming growth factor β (TGF-β) plays an important role in normal development and
homeostasis. Dysregulation of TGF-β responsiveness and its downstream signaling …
homeostasis. Dysregulation of TGF-β responsiveness and its downstream signaling …
[HTML][HTML] Galectin-3 activation and inhibition in heart failure and cardiovascular disease: an update
Galectin-3 is a versatile protein orchestrating several physiological and pathophysiological
processes in the human body. In the last decade, considerable interest in galectin-3 has …
processes in the human body. In the last decade, considerable interest in galectin-3 has …
Transforming growth factor-β receptors and Smads: regulatory complexity and functional versatility
EH Budi, D Duan, R Derynck - Trends in cell biology, 2017 - cell.com
Transforming growth factor (TGF)-β family proteins control cell physiology, proliferation, and
growth, and direct cell differentiation, thus playing key roles in normal development and …
growth, and direct cell differentiation, thus playing key roles in normal development and …
[HTML][HTML] MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling
Inhibitors of the ALK and EGF receptor tyrosine kinases provoke dramatic but short-lived
responses in lung cancers harboring EML4-ALK translocations or activating mutations of …
responses in lung cancers harboring EML4-ALK translocations or activating mutations of …
A systems toxicology approach to the surface functionality control of graphene–cell interactions
N Chatterjee, HJ Eom, J Choi - Biomaterials, 2014 - Elsevier
The raised considerable concerns about the possible environmental health and safety
impacts of graphene nanomaterials and their derivatives originated from their potential …
impacts of graphene nanomaterials and their derivatives originated from their potential …
FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation
CF Tu, MY Wu, YC Lin, R Kannagi, RB Yang - Breast Cancer Research, 2017 - Springer
Background Core fucosylation (addition of fucose in α-1, 6-linkage to core N-
acetylglucosamine of N-glycans) catalyzed by fucosyltransferase 8 (FUT8) is critical for …
acetylglucosamine of N-glycans) catalyzed by fucosyltransferase 8 (FUT8) is critical for …
The activation of PPARγ enhances Treg responses through up-regulating CD36/CPT1-mediated fatty acid oxidation and subsequent N-glycan branching of TβRII/IL …
Y Miao, C Zhang, L Yang, X Zeng, Y Hu, X Xue… - Cell Communication and …, 2022 - Springer
Background Peroxisome proliferator-activated receptor gamma (PPARγ) is an enhancer of
Treg responses, but the mechanisms remain elusive. This study aimed to solve this problem …
Treg responses, but the mechanisms remain elusive. This study aimed to solve this problem …
Glycosylation as a main regulator of growth and death factor receptors signaling
I Gomes Ferreira, M Pucci, G Venturi… - International journal of …, 2018 - mdpi.com
Glycosylation is a very frequent and functionally important post-translational protein
modification that undergoes profound changes in cancer. Growth and death factor receptors …
modification that undergoes profound changes in cancer. Growth and death factor receptors …
ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer
X Sun, Z He, L Guo, C Wang, C Lin, L Ye… - Journal of Experimental …, 2021 - Springer
Background Radiotherapy is a conventional and effective local treatment for breast cancer.
However, residual or recurrent tumors appears frequently because of radioresistance. Novel …
However, residual or recurrent tumors appears frequently because of radioresistance. Novel …